NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/21/2024
Back to search
Official data from USPTO
RENUE X PHARMACY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
09/21/2024
Trademark type
Combined
Nice classes
35, 44
Filing date
06/21/2018
Registration date
02/19/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/21/2024
Last transaction
09/21/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
08/27/2017
First use in commerce
08/27/2017
Drawing code
3
Owner type
16
Owner location
FRISCO, TX, US
Examiner
FIRST, VIVIAN M
Current location
Historical data usage
Mark description
The mark consists of the word RENUE above the wording PHARMACY with the leg of the "R" in RENUE extending down create the letter "X", all of the foregoing to the left of a hexagon with multiple intersecting straight lines in it.
Holders and representatives
Holders
RENUE HOLDING LLC
R. P. (pessoa física)
Representatives
Darin M. Klemchuk Klemchuk PLLC
Technical classification
Nice Classes
Class 35Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Retail pharmacy services
Class 44
Pharmaceutical compounding services
Publications
History of USPTO decisions and trademark events.
29 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/21/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/21/2024
E815
TEAS SECTION 8 & 15 RECEIVED
03/18/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/19/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
08/01/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/01/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/01/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/01/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/01/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/01/2023
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
04/22/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/15/2019
ES7R
TEAS SECTION 7 REQUEST RECEIVED
03/21/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
02/19/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/04/2018
PUBO
PUBLISHED FOR OPPOSITION
12/04/2018
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/28/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/14/2018
ALIE
ASSIGNED TO LIE
10/26/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/10/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
10/10/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/10/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
10/10/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/10/2018
DOCK
ASSIGNED TO EXAMINER
10/10/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/29/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/28/2018
NWAP
NEW APPLICATION ENTERED
06/25/2018
Continuous trademark protection
Get notified about every new filing that threatens RENUE X PHARMACY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.